I’m excited to share a deeper look into my professional journey and the work I’m passionate about at the intersection of science, strategy, and innovation. With a background in biomedical engineering, venture capital, and healthcare commercialization, I’ve been fortunate to work on translating complex ideas into real-world impact. Here is my biography.

I’m grateful for the opportunity to reflect on my professional journey and share a more comprehensive view of my work across engineering, product development, and leadership. Over the past four decades, I’ve had the privilege of contributing to meaningful innovations, supporting talented teams, and tackling complex challenges across a wide range of industries. Here is my biography.

I’m excited to share a deeper look into my journey across biomedical engineering, GMP manufacturing, policy, and entrepreneurial real estate. From research and publications in neuroengineering to process leadership at Lonza and Zoetis, and hands-on stewardship through Highlanders Capital Three, my focus has been consistent: build what matters and govern with integrity. If our paths overlap in health, manufacturing, governance, or operations, I’d welcome a conversation. Here is my biography.

Christopher Roche is a seasoned medical device executive with over 23 years of experience driving innovation in orthopedic technology and global commercialization. As Senior Vice President of Extremities at Exactech, he has led the division’s transformation into a $200 million business while contributing over 140 peer-reviewed publications and securing 38 patents. A member of the AIMBE College of Fellows and a recognized thought leader, Christopher blends deep biomedical engineering expertise with strategic vision and a passion for mentoring and global collaboration.

Dr. Lukas J. Farbiak is a biomedical engineering innovator and academic leader whose work in genetic medicine is transforming how diseases are treated at the molecular level. As an Assistant Professor at UT Southwestern and Co-Founder of Signify Bio, Inc., he merges deep scientific expertise with translational impact—developing advanced lipid nanoparticle platforms and signal peptide technologies that enable precise, tissue-specific delivery of therapeutic nucleic acids. With over 15 peer-reviewed publications and 20+ patent filings, Dr. Farbiak stands at the cutting edge of non-viral drug delivery and personalized therapeutics, bringing a rare blend of academic rigor, entrepreneurial vision, and collaborative leadership to every endeavor.

Ken Arnold is an accomplished medical device executive recognized for leading breakthrough innovations in laser technology and transforming companies through strategic vision and hands-on leadership. As CEO and Co-founder of Precise Light Surgical, he raised $17 million and guided the company from concept to commercialization with a novel tissue-sparing microsurgical platform. His earlier roles at Laserscope and Iridex underscore a consistent track record of scaling innovation into clinical and commercial success, including driving a $715 million acquisition and spearheading next-generation glaucoma treatments. With deep technical expertise, strong investor and clinical relationships, and a relentless focus on patient impact, Ken has built a career defined by precision, performance, and purpose.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

Excited to share my professional biography, highlighting my journey in the medical device industry, my expertise in quality systems and regulatory compliance, and my passion for driving innovation in healthcare technology. With over a decade of experience, I continue to focus on advancing medical devices through strategic quality initiatives and global regulatory alignment.

I’m excited to share my executive biography, highlighting my experience in R&D, regulatory strategy, and product innovation within the medical device industry. As I transition into board and advisory roles, I look forward to leveraging my expertise to help med-tech companies scale, innovate, and navigate regulatory landscapes.